Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Support Broke - Time to go ALL IN

<< Previous

Bullboard Posts

Next >>

Comment by TeddyTenBagson Mar 05, 2021 11:50pm

422 Views

Post# 32735314

RE:Support Broke - Time to go ALL IN

"Hey Guys, me again! Just wanted to confirm to all of you once again that I have no clue what I'm talking about as I draw meaningless lines on the charts, only to tell you the stock will either go up or down after watching me for 20 minutes! Let's dive into it!"

Completely useless videos for a 100% speculative stock play.